Therefore, based on this systemic analysis, we can pinpoint that ACE2 and CXCL10 are possible biomarkers whose higher expressions are responsible for the greater susceptibility and fatality of lung cancer patients towards the COVID-19 infection. Here, CXCL10 is linked to lung cancer.